PYC Therapeutics Limited (ASX:PYC)
Australia flag Australia · Delayed Price · Currency is AUD
1.480
-0.020 (-1.33%)
At close: Mar 9, 2026

PYC Therapeutics Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2020 - 2016
Market Capitalization
1,440755560191207493
Upgrade
Market Cap Growth
141.03%34.90%192.66%-7.47%-58.06%46.25%
Upgrade
Enterprise Value
1,320708536175165438
Upgrade
Last Close Price
1.481.261.170.540.621.49
Upgrade
PS Ratio
70.0232.1525.3812.1012.89160.37
Upgrade
PB Ratio
9.774.446.916.735.149.14
Upgrade
P/TBV Ratio
10.044.567.338.145.9210.19
Upgrade
EV/Sales Ratio
64.2030.1224.2911.1010.26142.63
Upgrade
Debt / Equity Ratio
0.010.010.010.010.020.01
Upgrade
Net Debt / Equity Ratio
-0.81-0.89-0.81-0.54-0.70-0.94
Upgrade
Net Debt / EBITDA Ratio
2.332.881.730.672.062.77
Upgrade
Net Debt / FCF Ratio
1.812.891.690.611.274.10
Upgrade
Asset Turnover
0.180.170.340.380.310.07
Upgrade
Quick Ratio
13.9214.389.323.798.9315.68
Upgrade
Current Ratio
13.9614.419.403.798.9515.71
Upgrade
Return on Equity (ROE)
-47.55%-40.64%-69.61%-68.05%-30.37%-44.29%
Upgrade
Return on Assets (ROA)
-28.68%-24.42%-37.83%-35.49%-17.29%-26.20%
Upgrade
Return on Capital Employed (ROCE)
-35.20%-31.40%-47.30%-81.50%-34.90%-34.30%
Upgrade
Earnings Yield
-3.30%-6.66%-6.74%-11.91%-6.71%-3.60%
Upgrade
FCF Yield
-4.60%-6.96%-6.95%-13.02%-10.72%-2.51%
Upgrade
Buyback Yield / Dilution
-27.58%-27.16%-22.59%-0.93%-2.89%-12.58%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.